A curated gathering of 25–30 senior pharmaceutical and biotechnology leaders for focused discussion, strategic insight, and meaningful relationship-building.
The Pharmalyzer Discovery Breakfast is designed exclusively for senior pharmaceutical and biotechnology professionals. With a carefully curated audience of 20–30 executives, the event prioritizes quality conversations, practical insights, and strategic networking over large-format presentations.
Meet peers and decision-makers from leading pharmaceutical and biotechnology organizations.
Executive-level conversations addressing real-world drug discovery challenges and opportunities.
Build relationships through curated introductions and focused, facilitated networking time.
Explore emerging approaches in AI, translational medicine, biomarkers, and precision drug development.
Modern drug discovery faces increasing pressure to improve translational success, reduce development timelines, and make better early-stage decisions. This executive breakfast explores how artificial intelligence, biomarkers, computational biology, and translational science are helping organizations improve predictability and therapeutic outcomes.
Exploring how machine learning and AI platforms are identifying and validating novel therapeutic targets with greater speed and confidence.
Leveraging biomarkers to improve go/no-go decisions, enhance patient stratification, and reduce late-stage failures across pipelines.
Bridging the gap between preclinical research and clinical application, and where the industry's biggest translational bottlenecks lie.
How computational approaches are reshaping drug design, ADMET prediction, and multi-omics integration in modern R&D.
Strategies and tools that are genuinely moving the needle on preclinical-to-clinical translation success rates across therapeutic areas.
A forward-looking conversation on what drug discovery will look like in 2030, from autonomous research to personalized medicine at scale.
This event is exclusively designed for senior decision-makers and scientific leaders within pharmaceutical and biotechnology organisations. All attendance requests are reviewed and subject to approval.
VP Drug Discovery
Head of Discovery Research
Head of Translational Medicine
Director Computational Biology
Biomarker Strategy Leaders
Precision Medicine Leaders
Senior Preclinical R&D Executives
Chief Scientific Officers
Drug Discovery Scientists
Translational Research Leaders
AI & Data Science Leaders
Therapeutic Area Heads
We are in the process of confirming senior industry leaders and scientific experts to lead discussions across our panel, roundtable, and fireside sessions. Speaker announcements coming soon.
Be the first to know when speakers are confirmed
Request Your Invitation
The breakfast will be hosted at a premium executive venue in San Diego designed to encourage discussion, networking, and collaboration in a comfortable and professionally curated environment.
Specific venue details, including address, parking, and logistics, will be shared exclusively with confirmed attendees ahead of the event.
The Pharmalyzer Discovery Breakfast offers an exclusive opportunity to connect with a carefully selected audience of pharmaceutical and biotechnology executives at one of the most focused senior gatherings in the drug discovery calendar.
As the exclusive Strategic Industry Partner, your organisation gains unrivalled visibility and access to 25–30 senior drug discovery decision-makers in an intimate, high-trust environment.
Only one Strategic Industry Partner will be selected for this event. Speak with our team to explore whether this opportunity aligns with your organisation's goals.
To maintain the quality of discussion and networking, attendance is strictly limited to approximately 25–30 senior industry professionals. All registrations are subject to review and approval by the Pharmalyzer Global team.
All fields required. Subject to approval.
Be part of an exclusive executive gathering exploring how AI, biomarkers, and translational medicine are transforming therapeutic innovation. San Diego, September 17, 2026.
